Antibacterial resistance occurs when antibiotics fail to treat bacterial infections. This incidence is considered one of the top global health threats, stemming from the misuse or overuse of antibiotics in humans and animals.1
The global impact of antibacterial resistance
Bacterial infections are common and can impact various organs and tissues in the human body.² Clinicians typically prescribe antibiotics to treat these infections; however, many bacteria have developed resistance to these treatments, including those considered the “last line of defense,” such as vancomycin and polymyxin. The prevalence of multi-drug-resistant (MDR) bacteria is well-documented.
In 2015, the World Health Organization initiated the Global Antimicrobial Resistance and Use Surveillance System (GLASS) to monitor antimicrobial resistance globally.³ The 2022 GLASS data showed a significant rise in antibiotic resistance, reducing the effectiveness of commonly used antibiotics against widespread bacterial infections.
Methicillin-resistant Staphylococcus aureus (MRSA) and third-generation cephalosporin-resistant Escherichia coli (E. coli) have been reported in 76 countries. In 2020, one in five individuals was diagnosed with urinary tract infections caused by E. coli, which showed reduced responsiveness to commonly prescribed antibiotics, including ampicillin, fluoroquinolones, and co-trimoxazole. Additionally, Klebsiella pneumoniae, an intestinal bacterium, exhibited increased antibiotic resistance.³
The Organization for Economic Cooperation and Development (OECD) projects a twofold increase in resistance to last-resort antibiotics by 2035. These findings emphasize the urgent need for innovative strategies to combat antibacterial resistance and underscore the importance of expanding global surveillance efforts.
Drug-design strategies to overcome antibacterial resistance
Most currently available antibiotics are derived from discoveries made before 2010. Given the increasing antibacterial resistance to many common antibiotics, there is an urgent need to develop new antibacterial agents that can effectively target a broad range of bacterial strains. Below are some of the key innovative drug-design strategies being explored to address bacterial resistance.
Antimicrobial Peptides (AMPs)
A range of AMPs have been designed to combat bacterial resistance.⁴ For instance, the antibiofilm peptide SAAP-148, derived from the parent peptide LL-37, has shown high efficacy against MDR pathogens.⁵ Proline-rich AMPs (PrAMPs), with multiple intracellular targets and low toxicity, are promising candidates, especially for eliminating Gram-negative pathogens. Commercially available peptide antimicrobials, such as polymyxin and short bacillus peptide, are currently used for therapeutic purposes.
Adjuvants
Efflux pump inhibitors (EPIs) and enzymatic inhibitors are commonly used as adjuvants to enhance antibiotic efficacy.⁶ For example, β-lactamase inhibitors are combined with β-lactam antibiotics to prevent the hydrolysis of the antibiotic’s lactam ring, preserving its structural integrity and antibacterial effectiveness.
Efflux pumps contribute significantly to both intrinsic and acquired bacterial resistance.⁷ Current research focuses on identifying and inhibiting EPIs to restore the potency of existing antibiotics. For instance, NorA, a chromosomally encoded multidrug efflux pump in MRSA, can be inhibited with synthetic antigen-binding fragments (Fabs).⁸
Nanomaterials
Metal-based nanomaterials, including zinc, silver, and gold, are utilized for bacterial infection detection and treatment. The antibacterial properties of these nanomaterials depend on their shape, size, and composition. Silver nanoparticles are widely used in biosensing, drug delivery, and antimicrobial wound dressings. Recent research highlights the effectiveness of gold nanoparticles against antibiotic-resistant bacteria.⁹
Cationic polymers, such as chitosan, polyquaternary ammonium salts (PQASs), and polyethyleneimine (PEI), possess intrinsic antibacterial properties.¹⁰ These positively charged materials interact with negatively charged bacterial surfaces, damaging bacterial cell walls or membranes and leading to bacterial cell death.
Phytochemicals
Plants produce secondary metabolites with antibacterial properties, such as phenols, coumarin alkaloids, and organosulfur compounds found in seeds, roots, leaves, stems, flowers, and fruits.¹¹ These compounds are promising candidates for addressing antibacterial resistance.
Plant extracts and essential oils are under study for their potential to modify bacterial antibiotic resistance. Mechanistically, secondary metabolites inhibit efflux pumps, biofilm synthesis, bacterial cell wall synthesis, and bacterial physiology, modulating antibiotic susceptibility. Studies show that alkaloids and phenolic compounds can inhibit the efflux pumps in Staphylococcus aureus, E. coli, and MRSA.
RNA silencing
RNA silencing, a natural bacterial gene regulation mechanism, involves complementary cis and trans sequences that interact with regulatory regions on mRNA (antisense sequences). Synthetic antisense sequences can be designed to inhibit the translation of resistance-associated enzymes.¹²
CRISPR-Cas system
The CRISPR-Cas system (clustered regularly interspersed short palindromic repeats-associated protein) is an adaptive immune system in bacteria, protecting against viruses, phages, and foreign genetic material.¹³
As a genetic engineering tool, CRISPR-Cas can selectively target and modify bacterial genomes, potentially reducing or eliminating antibiotic resistance. This strategy shows promise in treating MDR infections.¹⁴
Phage therapy
Although phage therapy has been available for decades, its use declined with the advent of antibiotics. The recent rise in antibiotic resistance has reignited interest in phage therapy. For example, phage therapy successfully treated a cystic fibrosis patient infected with drug-resistant Mycobacteroides abscessus.¹⁵ Bacteriophages have also shown efficacy in treating elderly patients with S. aureus prosthetic joint infections.¹⁶
Drug delivery systems
Drug delivery systems (DDSs) increase antibiotic biodistribution and bioavailability. This strategy can effectively reduce antibiotic resistance and prolong novel antibiotics’ lifespan. Scientists adopted a “Trojan horse” strategy in designing and developing DDSs.
This strategy entails merging antibacterial agents with different carriers, such as exosomes, liposomes, erythrocytes, self-assembled peptides, and polymers. By targeting the unique microenvironment of infected tissue or via external guidance, DDSs enable drug release at the specific site.16
Future research outlook
The availability of various antibiotic types resulted in the development of complex mechanisms of resistance, particularly the emergence of MDR bacteria. To combat the situation, scientists are focused on uncovering the bactericidal mechanism of antibiotics and the mechanism of bacterial resistance.
The advancements in material science, nanotechnology, and gene editing tools have presented multiple opportunities for this strand of research. DDS technology has also exhibited immense potential in helping overcome bacterial resistance in the future.
References
- Mancuso G, et al. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens. 2021;10(10):1310. doi: 10.3390/pathogens10101310.
- Doron S, Gorbach SL. Bacterial Infections: Overview. International Encyclopedia of Public Health. 2008:273–82. doi: 10.1016/B978-012373960-5.00596-7.
- Antimicrobial resistance. World Health Organization; https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. 2023; Assessed on October 5, 2024.
- Xuan J, et al. Antimicrobial peptides for combating drug-resistant bacterial infections. Drug Resistance Updates. 2023; 68, 100954. doi.org/10.1016/j.drup.2023.100954
- Shi J. et al. The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections. Commun Biol. 2022;5, 926. doi.org/10.1038/s42003-022-03899-4
- El-Khoury C, et al. The role of adjuvants in overcoming antibacterial resistance due to enzymatic drug modification. RSC Med Chem. 2022;13(11):1276-1299. doi: 10.1039/d2md00263a.
- Gaurav A, et al. Role of bacterial efflux pumps in antibiotic resistance, virulence, and strategies to discover novel efflux pump inhibitors. Microbiology (Reading). 2023;169(5):001333. doi: 10.1099/mic.0.001333.
- Brawley DN, et al. Structural basis for inhibition of the drug efflux pump NorA from Staphylococcus aureus. Nat Chem Biol. 2022;18(7):706-712. doi: 10.1038/s41589-022-00994-9.
- Rizvi SMD, et al. Antibiotic-Loaded Gold Nanoparticles: A Nano-Arsenal against ESBL Producer-Resistant Pathogens. Pharmaceutics. 2023;15(2):430. doi: 10.3390/pharmaceutics15020430.
- Carmona-Ribeiro AM, de Melo Carrasco LD. Cationic antimicrobial polymers and their assemblies. Int J Mol Sci. 2013;14(5):9906-46. doi: 10.3390/ijms14059906.
- Ashraf MV, et al. Phytochemicals as Antimicrobials: Prospecting Himalayan Medicinal Plants as Source of Alternate Medicine to Combat Antimicrobial Resistance. Pharmaceuticals. 2023; 16(6):881. doi.org/10.3390/ph16060881
- Jani S, et al. Silencing Antibiotic Resistance with Antisense Oligonucleotides. Biomedicines. 2021;9(4):416. doi: 10.3390/biomedicines9040416.
- Xu Y, Li Z. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J. 2020;18:2401-2415. doi: 10.1016/j.csbj.2020.08.031.
- Tao S, et al. The Application of the CRISPR-Cas System in Antibiotic Resistance. Infect Drug Resist. 2022;15:4155-4168. doi: 10.2147/IDR.S370869.
- Recchia D, et al. Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. Int J Mol Sci. 2023;24(5):4635. doi: 10.3390/ijms24054635.
- Yao J, et al. Recent Advances in Strategies to Combat Bacterial Drug Resistance: Antimicrobial Materials and Drug Delivery Systems. Pharmaceutics. 2023;15(4):1188. doi: 10.3390/pharmaceutics15041188.
News
Nanodiscs: What Are They and How Are They Shaping the Future of Medicine?
Nanodiscs are synthetic phospholipid particles with a distinct morphology and size that enhance their efficiency in drug delivery applications.1 First developed by Sligar et al. in the early 2000s, these model membrane systems measure around 10 [...]
New Discovery Reveals How Ovarian Cancer Starves Immune Cells
Researchers discovered that ovarian tumors hinder T cells’ energy supply by trapping a key protein, blocking lipid uptake. A new approach to reprogram T cells could enhance immunotherapy for aggressive cancers. Researchers at Weill Cornell [...]
Innovative Drug-Design Strategies to Overcome Antibacterial Resistance
Antibacterial resistance occurs when antibiotics fail to treat bacterial infections. This incidence is considered one of the top global health threats, stemming from the misuse or overuse of antibiotics in humans and animals.1 The [...]
Team introduces a cost-effective method to redesign search engines for AI
The internet search engine of the future will be powered by artificial intelligence. One can already choose from a host of AI-powered or AI-enhanced search engines—though their reliability often still leaves much to be [...]
Experiments demonstrate precise delivery of nanoparticles to lung
In recent years, bio-medical engineers have been developing promising techniques that could help diagnose diseases or precisely target specific regions inside the human body. Among these promising therapeutic strategies are methods that rely on [...]
What is Lassa fever? Everything to know about Ebola-like virus
Lassa fever has reached the US for the first time in a decade, in a case that has surprised health officials. The middle-aged patient in Iowa, who was not identified, died a 'short time' after being hospitalized [...]
Harvard Study Links Popular Plastic Ingredient to DNA Damage
Phthalate affects egg formation in C. elegans, resulting in abnormal chromosome numbers. A recent study conducted on roundworms has discovered that a common plastic ingredient can cause DNA strand breaks, leading to egg cells with an abnormal [...]
New research finds that subtle eye movements optimize vision
Our ability to see starts with the light-sensitive photoreceptor cells in our eyes. A specific region of the retina, termed fovea, is responsible for sharp vision. Here, the color-sensitive cone photoreceptors allow us to [...]
Scientists Were Wrong: Plants Absorb 31% More CO2 Than Previously Thought
New research shows plants absorb 31% more CO2 than previously estimated, raising the global GPP to 157 petagrams per year. Using carbonyl sulfide as a proxy for photosynthesis, this study highlights tropical rainforests’ critical role [...]
Doctors test first mRNA vaccine against norovirus
According to the Robert Koch Institute (RKI), the norovirus, which is widespread worldwide, is the cause of a large proportion of gastrointestinal infections. Those who catch the virus suffer from nausea, diarrhea and vomiting. [...]
Study reveals resistance of Pseudomonas aeruginosa to common cleaning agents
A new study reveals widespread resistance of a major bacterial pathogen to the active ingredients in cleaning agents commonly used in hospitals and homes. The American Chemical Society Infectious Diseases published the research, led [...]
AI’s Next Frontier: System 0 and the Future of Human Thought
“System 0” represents an emerging cognitive tool powered by AI that works alongside human intuition and analysis to enhance cognitive abilities. This new system promises to support complex decision-making and problem-solving but requires careful [...]
The Global Nanomedicine Market: Key Players and Emerging Technologies in Healthcare
This article provides an overview of the global nanomedicine market, highlighting key players, emerging technologies, and the challenges and opportunities that influence its growth and commercialization in the healthcare sector. Nanomedicines are nanotechnology-based drug products [...]
Scientists Have Discovered Toxic “Forever Chemicals” in Bottled Water
Scientists have found toxic PFAS in drinking water samples from around the world, with higher levels in tap water from China compared to the UK. Boiling water or using a filtration jug can reduce [...]
Urban Microbes Are Eating Disinfectants – Are We Fueling a New Health Threat?
New research reveals that microbes in urban environments are evolving to withstand the very cleaning agents designed to eliminate them. The study also uncovers new strains in Hong Kong, previously only found in the [...]
Startling Study Shows High-Potency Cannabis Alters DNA
The study shows that frequent use of high-potency cannabis alters DNA, affecting genes related to energy and immune function. These changes differ between those with and without psychosis, suggesting cannabis use could influence mental health through biological [...]